Covid 19-how is the exposure of the pediatric population? A systematic review protocol

ABSTRACT

Solid information on exposure and how to treat COVID-19 in pediatric patients is not yet conclusive in the literature, because of this it is necessary to make a critical analysis of the available data in order to provide common points on the theme in question. This systematic review protocol is registered in PROSPERO (ID CRD42020181835) and aims through searches in the Databases PubMed, Google Scholar, LILACS and CINAHL, to group the studies published with the theme COVID-19 and pediatric between 2019 and 2020. The MeSH descriptors COVID-19, child and children will be used in English and Chinese. Observational research, clinical trials and literature reviews will be included, where the study sample was composed of pediatric patients of both sexes aged between 6 and 17 years. The Rayyan QCRI tool® will be used to manage revision data. The analysis of the feasibilities of observational studies will be done by the Loney scale, clinical trials by the Cocharne scale and review studies by the Overview Quality Assessment Questionnaire (OQAQ). The authors intend that the study is completed in the second semester of 2021. The choice of the theme is justified because the results of the future research are useful for the elaboration of public health measures that offer the promotion of effective treatment during the recovery of pediatric patients infected with COVID-19.